Role of Smac in human leukaemic cell apoptosis and proliferation

Oncogene

Volumn 22, Issue 11, 2003, Pages 1589-1599

  Jia, Li ^a   Patwari, Yasmeen ^a   Kelsey, Stephen M ^a   Srinivasula, Srinivasa M ^b   Agrawal, Samir G ^a   Alnemri, Emad S ^b   Newland, Adrian C ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Apaf 1; Apoptosis; Caspases; IAPs; Smac

Indexed keywords

APOPTOTIC PROTEASE ACTIVATING FACTOR 1; BROXURIDINE; CASPASE 3; CASPASE 9; CYTOCHROME C; INHIBITOR OF APOPTOSIS PROTEIN; KI 67 ANTIGEN; PEPTIDE DERIVATIVE; PEPTIDE SMAC N 7; PROTEIN DERIVATIVE; RECOMBINANT PROTEIN; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS;

ACUTE GRANULOCYTIC LEUKEMIA; ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BLAST CELL; CANCER RESISTANCE; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELL STRAIN K 562; COLONY FORMATION; CONTROLLED STUDY; CYTOSOL; DRUG ACTIVITY; DRUG POTENTIATION; DRUG SENSITIVITY; ENZYME ACTIVATION; ENZYME ASSAY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA CELL; LEUKEMIA CELL LINE; MATURITY; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE GENETICS; RADIOSENSITIVITY; ULTRAVIOLET RADIATION;

APOPTOSIS; APOPTOTIC PROTEASE-ACTIVATING FACTOR 1; CARRIER PROTEINS; CASPASES; CELL DIVISION; CYTOCHROME C GROUP; ENZYME ACTIVATION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKEMIA; MITOCHONDRIAL PROTEINS; PROTEINS; RECOMBINANT PROTEINS; TRANSFECTION; TUMOR CELLS, CULTURED; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

INTRACISTERNAL A-PARTICLES;

EID: 0037456993     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206322     Document Type: Article

References (33)

1. Altieri DC. (2001). Trends Mol. Med., 7, 542-547.
2. Carson JP, Behnam M, Sutton JN, Du C, Wang X, Hunt DF, Weber MJ and Kulik G. (2002). Cancer Res., 62, 18-23.
3. Chai J, Du C, Wu JW, Kyin S, Wang X and Shi Y. (2000). Nature, 406, 855-862.
4. Deng Y, Lin Y and Wu X. (2002). Genes Dev., 16, 33-45.
5. Deveraux QL, Roy N, Stennicke HR, Van Arsdale T, Zhou Q, Srinivasula SM, Alnemri ES, Salvesen GS and Reed JC. (1998). EMBO J., 17, 2215-2223.
6. Du C, Fang M, Li Y, Li L and Wang X. (2000). Cell, 102, 33-42.
7. Ekert PG, Silke J, Hawkins CJ, Verhagen AM and Vaux DL. (2001). J. Cell Biol., 152, 483-490.
8. Fulda S, Kufer MU, Meyer E, van Valen F, Dockhorn-Dworniczak B and Debatin KM. (2001). Oncogene, 20, 5865-5877.
9. Fulda S, Wick W, Weller M and Debatin KM. (2002). Nat. Med., 8, 808-815.
10. Gerlach C, Kubbutat M, Schwab V, Key G, Flad HD and Gerdes J. (1998). Lab. Invest., 78, 129-130.
11. Green DR and Reed JC. (1998). Science, 281, 1309-1312.
12. Guo F, Nimmanapalli R, Paranawithana S, Wittman S, Griffin D, Bali P, O'Bryan E, Fumero C, Wang HG and Bhalla K. (2002). Blood, 99, 3419-3426.
13. Hegde R, Srinivasula SM, Zhang Z, Wassell R, Mukattash R, Cilenti L, DuBois G, Lazebnik Y, Fernandes-Alnemri T and Alnemri ES. (2002). J. Biol. Chem., 277, 432-438.
14. Jia L, Macey MG, Yin Y, Newland AC and Kelsey SM. (1999). Blood, 93, 2353-2359.
15. Jia L, Patwari Y, Kelsey SM and Newland AC. (2001a). Biochem. Biophys. Res. Commun., 283, 1037-1045.
16. Jia L, Patwari Y, Srinivasula SM, Newland AC, Alnemri ES and Kelsey SM. (2001b). Oncogene, 20, 4817-4826.
17. Jia L, Srinivasula SM, Liu FT, Newland AC, Alnemri ES and Kelsey SM. (2001c). Blood, 98, 414-421.
18. Kabra NH, Kang C, Hsing LC, Zhang J and Winoto A. (2001). Proc. Natl. Acad. Sci. USA, 98, 6307-6312.
19. Liu FT, Kelsey SM, Newland AC and Jia L. (2002). Br. J. Haematol., 117, 333-342.
20. Liu X, Kim CN, Yang J, Jemmerson R and Wang X. (1996). Cell, 86, 147-157.
21. Li LY, Luo X and Wang X. (2001). Nature, 412, 95-99.
22. Liu Z, Sun C, Olejniczak ET, Meadows RP, Betz SF, Oost T, Herrmann J, Wu JC and Fesik SW. (2000). Nature, 408, 1004-1008.
23. Partheniou F, Kelsey SM, Srinivasula SM, Newland AC, Alnemri ES and Jia L. (2001). Biochem. Biophys. Res. Commun., 287, 181-189.
24. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin KM, Krammer PH and Peter ME. (1998). EMBO J., 17, 1675-1687.
25. Srinivasula SM, Datta P, Fan XJ, Fernandes-Alnemri T, Huang Z and Alnemri ES. (2000). J. Biol. Chem., 275, 36152-36157.
26. Srinivasula SM, Hegde R, Saleh A, Datta P, Shiozaki E, Chai J, Lee RA, Fernandes-Alnemri T, Shi Y and Alnemri ES. (2001). Nature, 410, 112-116.
27. Suliman A, Lam A, Datta R and Srivastava RK. (2001). Oncogene, 20, 2122-2133.
28. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler M and Kroemer G. (1999). Nature, 397, 441-446.
29. Tamm I, Kornblau SM, Segall H, Krajewski S, Welsh K, Kitada S, Scudiero DA, Tudor G, Qui YH and Reed JC. (2000). Clin. Cancer Res., 6, 1796-1803.
30. Terry NHA and White RA (2001). Methods Cell. Biol., 63, 355-374.
31. Verhagen AM, Ekert PG, Pakusch M, Silke J, Connolly LM, Reid GE, Moritz RL, Simpson RJ and Vaux DL. (2000). Cell, 102, 43-53.
32. Zang DY, Goodwin RG, Loken MR, Bryant E and Deeg HJ. (2001). Blood, 98, 3058-3065.
33. Zhang XD, Zhang XY, Gray CP, Nguyen T and Hersey P. (2001). Cancer Res., 61, 7339-7348.